First Midwest Bank Trust »

Aurinia Pharmaceuticals shares owned by First Midwest Bank Trust

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by First Midwest Bank Trust from 13F filings

Historical chart of First Midwest Bank Trust investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by First Midwest Bank Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by First Midwest Bank Trust

Quarter filed Position value Share count Share price at filing
2021-12-31 $651k 29k 22.88

More positions owned by First Midwest Bank Trust

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Whitehall Fds High Div Yld (VYM)
Deere & Company (DE)
Ishares Tr Russell 2000 Etf (IWM)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p500 Etf (IVV)
JPMorgan Chase & Co. (JPM)
Nextera Energy (NEE)
Eli Lilly & Co. (LLY)
Procter & Gamble Company (PG)
UnitedHealth (UNH)
McDonald's Corporation (MCD)
Ishares Tr Msci Acwi Etf (ACWI)

View all positions for First Midwest Bank Trust

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals